1. Non-specific inhibition of some rat liver membrane-bound enzymes by an adenylate cyclase inhibitor, RMI 12330 A
- Author
-
Jacques Hanoune, Jean-Louis Mahu, Pierre Berthelot, Georges Guellaen, and Philippe Mavier
- Subjects
ATPase ,Adenylate kinase ,Cyclopentanes ,In Vitro Techniques ,Biology ,Biochemistry ,Cyclase ,Leucyl Aminopeptidase ,medicine ,Animals ,Glucuronosyltransferase ,Adenosine Triphosphatases ,Pharmacology ,chemistry.chemical_classification ,Kidney ,Cell Membrane ,Molecular biology ,Rats ,Enzyme ,Membrane ,medicine.anatomical_structure ,Liver ,chemistry ,Adenylyl Cyclase Inhibitors ,Glucose-6-Phosphatase ,Microsomes, Liver ,Microsome ,biology.protein ,Female ,Imines ,Cyclase activity - Abstract
RMI 12330 A [ N -( cis -2-phenlcyyclopentyl) azacyclotridecan-2-imine hydrochloride] inhibits choleratoxin-induced intestinal hypersecretion, presumably via an inhibition of the mucosal enzyme adenylate cyclase. We previously reported the inhibition by RMI 12330 A of the adenylate cyclase activity from rat liver plasma membrane preparations. We firstly extend here these results, showing the inhibition by RMI 12330 A of adenylate cyclase activity from spleen, brain, heart and kidney. Furthermore, in plasma membrane preparations, this agent inhibited the activities of Mg 2+ -ATPase and leucyl-β-naphthylamidase but had no effect upon 5′nucleotidase. In non-activated rat liver microsomes, the activities of p -nitrophenol and bilirubin UDP-glucuronosyltransferases, and of glucose-6-phosphatase, were enhanced by low concentrations of RMI 12330 A but inhibited by higher concentrations. This biphasic effect disappeared when digitonin-activated or Emulgen 911-solubilized microsomal membranes were used. Thus, RMI 12330 A does not behave as a specific inhibitor of adenylate cyclase, since it also perturbs other membrane-associated enzyme activities.
- Published
- 1978
- Full Text
- View/download PDF